Topics:
Breast Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Moffitt Cancer Center • HR+
How would you manage a postmenopausal female with a history of early stage invasive ductal ER+/HER2- breast cancer s/p mastectomy who has a local recurrence of ER+/Her2 - lobular carcinoma while on letrozole?
Answer from: Medical Oncologist at Community Practice
I am sure most of us would offer local resection and radiation therapy along with staging work up without consideration for chemotherapy given CALOR data showing no benefit in ER positive cases. The final analysis of CALOR does not support the use of chemotherapy for ER-positive isolated loco-region...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
I agree with treatment as per CALOR. However, since the CALOR, we now have increased understanding of primary and secondary endocrine resistance. In advanced breast cancer setting, we now have multiple preclinical and retrospective data sets that demonstrate that patients with ESR1 mutations h...
Comments
Medical Oncologist at Medical College of Wisconsin
While the CALOR study found no significant benefit...
While the CALOR study found no significant benefit...
Medical Oncologist at University of California Irvine Medical Center
Agree, results in CALOR in hormone receptor-positi...
Agree, results in CALOR in hormone receptor-positi...